Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 199

1.

Resveratrol mediates anti-atherogenic effects on cholesterol flux in human macrophages and endothelium via PPARγ and adenosine.

Voloshyna I, Hai O, Littlefield MJ, Carsons S, Reiss AB.

Eur J Pharmacol. 2013 Jan 5;698(1-3):299-309. doi: 10.1016/j.ejphar.2012.08.024. Epub 2012 Oct 4.

PMID:
23041272
2.

Apolipoprotein A-I but not high-density lipoproteins are internalised by RAW macrophages: roles of ATP-binding cassette transporter A1 and scavenger receptor BI.

Lorenzi I, von Eckardstein A, Cavelier C, Radosavljevic S, Rohrer L.

J Mol Med (Berl). 2008 Feb;86(2):171-83. Epub 2007 Oct 1.

PMID:
17906976
3.

A new insight into resveratrol as an atheroprotective compound: inhibition of lipid peroxidation and enhancement of cholesterol efflux.

Berrougui H, Grenier G, Loued S, Drouin G, Khalil A.

Atherosclerosis. 2009 Dec;207(2):420-7. doi: 10.1016/j.atherosclerosis.2009.05.017. Epub 2009 May 22.

PMID:
19552907
4.

Oxidized low density lipoprotein decreases macrophage expression of scavenger receptor B-I.

Han J, Nicholson AC, Zhou X, Feng J, Gotto AM Jr, Hajjar DP.

J Biol Chem. 2001 May 11;276(19):16567-72. Epub 2001 Feb 6.

5.

Inhibitory effects of resveratrol on foam cell formation are mediated through monocyte chemotactic protein-1 and lipid metabolism-related proteins.

Dong W, Wang X, Bi S, Pan Z, Liu S, Yu H, Lu H, Lin X, Wang X, Ma T, Zhang W.

Int J Mol Med. 2014 May;33(5):1161-8. doi: 10.3892/ijmm.2014.1680. Epub 2014 Feb 28.

PMID:
24584901
6.

Tanshinone IIA attenuates atherosclerosis in ApoE(-/-) mice through down-regulation of scavenger receptor expression.

Tang FT, Cao Y, Wang TQ, Wang LJ, Guo J, Zhou XS, Xu SW, Liu WH, Liu PQ, Huang HQ.

Eur J Pharmacol. 2011 Jan 10;650(1):275-84. doi: 10.1016/j.ejphar.2010.07.038. Epub 2010 Sep 17.

PMID:
20854809
7.

Atheroprotective effects of methotrexate on reverse cholesterol transport proteins and foam cell transformation in human THP-1 monocyte/macrophages.

Reiss AB, Carsons SE, Anwar K, Rao S, Edelman SD, Zhang H, Fernandez P, Cronstein BN, Chan ES.

Arthritis Rheum. 2008 Dec;58(12):3675-83. doi: 10.1002/art.24040.

8.

Spiromastixones Inhibit Foam Cell Formation via Regulation of Cholesterol Efflux and Uptake in RAW264.7 Macrophages.

Wu C, Chen R, Liu M, Liu D, Li X, Wang S, Niu S, Guo P, Lin W.

Mar Drugs. 2015 Oct 14;13(10):6352-65. doi: 10.3390/md13106352.

9.

PKCδ signalling regulates SR-A and CD36 expression and foam cell formation.

Lin CS, Lin FY, Ho LJ, Tsai CS, Cheng SM, Wu WL, Huang CY, Lian CH, Yang SP, Lai JH.

Cardiovasc Res. 2012 Aug 1;95(3):346-55. doi: 10.1093/cvr/cvs189. Epub 2012 Jun 11.

PMID:
22687273
10.

Resistin increases lipid accumulation by affecting class A scavenger receptor, CD36 and ATP-binding cassette transporter-A1 in macrophages.

Lee TS, Lin CY, Tsai JY, Wu YL, Su KH, Lu KY, Hsiao SH, Pan CC, Kou YR, Hsu YP, Ho LT.

Life Sci. 2009 Jan 16;84(3-4):97-104. doi: 10.1016/j.lfs.2008.11.004. Epub 2008 Nov 14.

PMID:
19041881
11.

Targeting mitochondrial 18 kDa translocator protein (TSPO) regulates macrophage cholesterol efflux and lipid phenotype.

Taylor JM, Allen AM, Graham A.

Clin Sci (Lond). 2014 Nov;127(10):603-13. doi: 10.1042/CS20140047.

PMID:
24814875
12.

Anti-atherosclerotic potential of baicalin mediated by promoting cholesterol efflux from macrophages via the PPARγ-LXRα-ABCA1/ABCG1 pathway.

He XW, Yu D, Li WL, Zheng Z, Lv CL, Li C, Liu P, Xu CQ, Hu XF, Jin XP.

Biomed Pharmacother. 2016 Oct;83:257-264. doi: 10.1016/j.biopha.2016.06.046. Epub 2016 Jul 4.

PMID:
27389392
13.

Anthocyanin extracted from Hibiscus attenuate oxidized LDL-mediated foam cell formation involving regulation of CD36 gene.

Kao ES, Tseng TH, Lee HJ, Chan KC, Wang CJ.

Chem Biol Interact. 2009 May 15;179(2-3):212-8.

PMID:
19330881
14.

Effects of lycopene on the induction of foam cell formation by modified LDL.

Napolitano M, De Pascale C, Wheeler-Jones C, Botham KM, Bravo E.

Am J Physiol Endocrinol Metab. 2007 Dec;293(6):E1820-7. Epub 2007 Oct 2.

15.
16.

Nicotine potentiates proatherogenic effects of oxLDL by stimulating and upregulating macrophage CD36 signaling.

Zhou MS, Chadipiralla K, Mendez AJ, Jaimes EA, Silverstein RL, Webster K, Raij L.

Am J Physiol Heart Circ Physiol. 2013 Aug 15;305(4):H563-74. doi: 10.1152/ajpheart.00042.2013. Epub 2013 Jun 7.

17.

Human scavenger protein AIM increases foam cell formation and CD36-mediated oxLDL uptake.

Amézaga N, Sanjurjo L, Julve J, Aran G, Pérez-Cabezas B, Bastos-Amador P, Armengol C, Vilella R, Escolà-Gil JC, Blanco-Vaca F, Borràs FE, Valledor AF, Sarrias MR.

J Leukoc Biol. 2014 Mar;95(3):509-20. doi: 10.1189/jlb.1212660. Epub 2013 Dec 2.

18.

Curcumin retunes cholesterol transport homeostasis and inflammation response in M1 macrophage to prevent atherosclerosis.

Chen FY, Zhou J, Guo N, Ma WG, Huang X, Wang H, Yuan ZY.

Biochem Biophys Res Commun. 2015 Nov 27;467(4):872-8. doi: 10.1016/j.bbrc.2015.10.051. Epub 2015 Oct 19.

PMID:
26471308
19.

Pentraxin 3 promotes oxLDL uptake and inhibits cholesterol efflux from macrophage-derived foam cells.

Liu W, Jiang J, Yan D, Li D, Li W, Ma Y, Yang L, Qu Z, Ruan Q.

Exp Mol Pathol. 2014 Jun;96(3):292-9. doi: 10.1016/j.yexmp.2014.03.007. Epub 2014 Mar 24.

PMID:
24675235
20.

Imbalanced response of ATP-binding cassette transporter A1 and CD36 expression to increased oxidized low-density lipoprotein loading contributes to the development of THP-1 derived foam cells.

Liu HY, Cui HB, Chen XM, Chen XY, Wang SH, Du WP, Zhou HL, Zhao RC, Zhou Y, Liu YH, Cui CC, Huang C.

J Biochem. 2014 Jan;155(1):35-42. doi: 10.1093/jb/mvt106.

PMID:
24394674

Supplemental Content

Support Center